News Mar 08, 2021 Debiopharm enters EUR 900+ million contract with Merck Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and n...
News Apr 27, 2018 Five reasons to register for the Aussenwirtschaftsforum now The Switzerland Global Enterprise Aussenwirtschaftsforum is the annual meeting of the Swiss export economy. Why is this year's event unmissable f...